An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer. Read more about An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer.
Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice. Read more about Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice.
BiPOLES is an optogenetic tool developed for bidirectional dual-color control of neurons. Read more about BiPOLES is an optogenetic tool developed for bidirectional dual-color control of neurons.
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells. Read more about Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.
Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Read more about Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons.
Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Read more about Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.
ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. Read more about ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress.
Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci. Read more about Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci.
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Read more about Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Publisher Correction: A meta-analysis of genome-wide association studies identifies multiple longevity genes. Read more about Publisher Correction: A meta-analysis of genome-wide association studies identifies multiple longevity genes.